PARAMETRIC PORTFOLIO ASSOCIATES LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$4,475,000
+31.1%
90,414
+34.9%
0.00%0.0%
Q4 2021$3,413,000
-8.3%
67,017
+0.5%
0.00%0.0%
Q3 2021$3,720,000
+76.9%
66,690
+35.7%
0.00%
+100.0%
Q2 2021$2,103,000
+26.6%
49,145
+23.5%
0.00%0.0%
Q1 2021$1,661,000
-4.6%
39,798
+6.4%
0.00%0.0%
Q4 2020$1,742,000
+63.3%
37,396
+48.9%
0.00%0.0%
Q3 2020$1,067,000
-10.9%
25,107
+0.7%
0.00%0.0%
Q2 2020$1,197,000
-0.7%
24,942
-4.8%
0.00%0.0%
Q1 2020$1,205,000
-36.6%
26,197
-17.2%
0.00%0.0%
Q4 2019$1,900,000
-7.0%
31,623
-12.4%
0.00%
-50.0%
Q3 2019$2,043,000
-10.7%
36,119
-12.1%
0.00%0.0%
Q2 2019$2,288,000
+33.2%
41,094
+20.8%
0.00%
+100.0%
Q1 2019$1,718,000
+123.1%
34,032
+78.1%
0.00%0.0%
Q4 2018$770,000
-21.8%
19,107
+34.5%
0.00%0.0%
Q3 2018$985,000
+6.3%
14,211
+16.0%
0.00%0.0%
Q2 2018$927,000
-6.1%
12,246
-34.6%
0.00%0.0%
Q1 2018$987,000
-6.4%
18,725
-5.2%
0.00%0.0%
Q4 2017$1,055,000
+7.0%
19,743
+19.4%
0.00%0.0%
Q3 2017$986,000
+66.3%
16,532
+120.0%
0.00%0.0%
Q2 2017$593,000
+86.5%
7,515
+95.9%
0.00%
Q1 2017$318,000
-75.9%
3,836
-76.9%
0.00%
-100.0%
Q4 2016$1,320,000
+366.4%
16,635
+311.5%
0.00%
Q3 2016$283,000
+36.7%
4,043
+73.0%
0.00%
Q4 2015$207,0002,3370.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders